SMARCA4 and neoplasm: Remarkably, there seems to be a striking organ-specific clustering of mutations in certain SWI/SNF genes, so that ARID1A mutations prevail in genital tract malignancies while SMARCB1 and SMARCA4 mutations predominate among SWI/SNF-driven neoplasms of soft tissue and lung, respectively [5].